A case report: preceding diagnosis of type 2 diabetes by severe neuropathic pain arising from diabetic polyneuropathy [0.03%]
一例病例报告：由糖尿病多发性神经病引起的严重神经痛继发2型糖尿病诊断后发生
Tatsuhito Himeno,Hiromi Nakai-Shimoda,Yusuke Hayashi et al.
Tatsuhito Himeno et al.
This report pertains to a 51-year-old male patient who sought medical attention with the chief complaint of generalized bodily pain. His symptoms commenced approximately six months prior, characterized initially by paresthesia in both lower...
Correction: Regulation of glucose metabolism by incretins: implications for treatment of type 2 diabetes [0.03%]
关于肠促胰素对葡萄糖代谢的调节作用及其在2型糖尿病治疗中的意义的更正公告
Rie Saito,Norio Harada
Rie Saito
[This corrects the article DOI: 10.1007/s13340-024-00781-y.]. © The Author(s) 2025.
Published Erratum
Diabetology international. 2025 Jun 9;16(3):447. DOI:10.1007/s13340-025-00826-w 2025
Improving postprandial hyperglycemia in prediabetic, sedentary office workers with immediately post-lunch, intermediate-intensity exercise: a comprehensive evaluation using a physical activity tracker, a dietary management application, and continuous glucose monitoring [0.03%]
使用身体活动跟踪器、饮食管理应用程序和连续葡萄糖监测，通过餐后中等强度运动改善前期糖尿病久坐办公工作人员餐后高血糖的综合评估方法
Keiko Koide,Koichiro Azuma,Yoshihito Atsumi
Keiko Koide
Aim/introduction: This study investigated if immediately post-lunch exercise may improve postprandial hyperglycemia in individuals with prediabetes. Mater...
Yoshiro Fushimi,Tomohiko Kimura,Junpei Sanada et al.
Yoshiro Fushimi et al.
We report a case of rhabdomyolysis triggered by initiation of tirzepatide, a novel dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The patient was a 68-year-old man with a me...
Periodontal disease and the incident risk of diabetes mellitus in Japanese men and women: a 12-year cohort study [0.03%]
日本男女12年随访研究：牙周病和糖尿病的发病风险关系研究
Kazuka Yoneda,Masaru Sakurai,Yoshiyuki Soyama et al.
Kazuka Yoneda et al.
Aims/introduction: This study assessed the association between periodontal disease and the development of diabetes mellitus, as well as the effects of sex differences and obesity on this association. ...
Renata Vargas,Adriana Pedreañez,Yenddy Carrero et al.
Renata Vargas et al.
The expression of angiotensin II (Ang II) has been reported in diabetes associated with hypertension and inflammatory processes. It has also been reported a link between Ang II, depression and diabetes; however, underlying mechanisms of Ang...
Comparing the anorexigenic effects and mechanisms of gut-derived GLP-1 and its receptor agonists: insights into incretin-based therapies for obesity [0.03%]
肠源性GLP-1及其受体激动剂的厌食作用和机制比较——基于肠降糖素疗法治疗肥胖的新见解
Yuta Masuda,Kento Ohbayashi,Yusaku Iwasaki
Yuta Masuda
Obesity continues to increase worldwide. The primary cause of obesity is overeating, but the development of pharmacological treatments for obesity related to overeating has taken longer than expected. Recently, agonists of glucagon-like pep...
Longitudinal monitoring of urinary C-peptide levels following discontinuation of sacubitril/valsartan in a type 2 diabetes patient: a case report and literature review [0.03%]
一例糖尿病患者停用沙库巴曲缬沙坦后尿C肽纵向水平监测及文献回顾
Keiichiro Kondo,Hiroto Minamino,Takaaki Murakami et al.
Keiichiro Kondo et al.
We report two cases of diabetes mellitus treated with sacubitril/valsartan, whose urinary C-peptide dynamics exhibited significant difference. The first case is an 84-year-old Japanese man with type 2 diabetes and hypertension who exhibited...
Evolving incretin-based therapies in Japan: optimizing treatment strategies for diverse clinical and socioeconomical profiles in type 2 diabetes [0.03%]
日本的肠降糖激素治疗的发展：优化2型糖尿病患者临床及社会经济学特征各异的治疗策略
Yohei Seno,Eri Ikeguchi,Daisuke Yabe
Yohei Seno
The management of type 2 diabetes has evolved significantly with the advent of incretin-based therapies, particularly dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists. In Japan, where over 70% of individuals w...